1995
DOI: 10.1016/1055-8330(95)90016-0
|View full text |Cite
|
Sign up to set email alerts
|

An endogenous dopaminergic neurotoxin: Implication for Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
104
1

Year Published

1998
1998
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(111 citation statements)
references
References 25 publications
2
104
1
Order By: Relevance
“…Some aldehyde metabolites are neurotoxic and their intraneuronal accumulation has been regarded as one mechanism that might be involved in cell death associated with neurodegenerative conditions, i ncluding Parkinson's disease and Alzheimer's disease (Mattammal et al 1995;Burke et al 2003). Thus, through inhibiting aldehyde dehydrogenases, MC-LR treatment could cause an accumulation of aldehyde, which results in oxidative stress (Wang et al 2010).…”
Section: Oxidative Stressmentioning
confidence: 99%
“…Some aldehyde metabolites are neurotoxic and their intraneuronal accumulation has been regarded as one mechanism that might be involved in cell death associated with neurodegenerative conditions, i ncluding Parkinson's disease and Alzheimer's disease (Mattammal et al 1995;Burke et al 2003). Thus, through inhibiting aldehyde dehydrogenases, MC-LR treatment could cause an accumulation of aldehyde, which results in oxidative stress (Wang et al 2010).…”
Section: Oxidative Stressmentioning
confidence: 99%
“…4-1): (a) Oxidation of DA produces a toxic semiquinone. The electron-deficient semiquinone reacts readily with nucleophilic compounds such as sulfhydryl (-SH) groups (Scheulen, et al, 1975;Graham et al, 1978;Ito, 1988 (Mattammal et al, 1993;Mattammal et al, 1995).…”
Section: Chapter 4 General Discussionmentioning
confidence: 99%
“…DOPAL is taken up by rat neostriatal synaptosomes, and studies using mazindol, a selective dopamine uptake inhibitor, have suggested that the aldehyde reenters dopaminergic nerve terminals via the dopamine transporter (DAT) (Mattammal et al, 1995). The DAT is expressed in presynaptic terminals of SN neurons where it primarily mediates the reuptake of neuronally released dopamine (Reith et al, 1997;Jones et al, 1998).…”
Section: B Transport Mechanismsmentioning
confidence: 99%
“…Dopamine is deaminated to 3,4-dihydroxyphenylacetaldehyde (DOPAL), and both norepinephrine and epinephrine are deaminated to form 3,4-dihydroxyphenylglycolaldehyde (DOPEGAL). Increasing evidence suggests that these catecholamine-derived aldehydes may in fact be neurotoxins, and their intraneuronal accumulation has been theorized as one mechanism that may be involved in cell death associated with neurodegenerative conditions, including Parkinson's disease (PD) and Alzheimer's disease (AD) (Mattammal et al, 1995;Burke et al, 2003). Aldehydes, including DOPAL and DOPEGAL, are detoxified by various enzyme systems including aldehyde dehydrogenase (ALDH), which is exclusively responsible for their oxidative metabolism ( Fig.…”
Section: Introductionmentioning
confidence: 99%